Stock 301065 ZHEJIANG BENLI TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zhejiang Benli Technology Co., Ltd.

Equities

301065

CNE100004RL8

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 22/05/2024 am IST 		5-day change 1st Jan Change
18.45 CNY -1.07% Intraday chart for Zhejiang Benli Technology Co., Ltd. -1.55% -18.90%
24/04 Zhejiang Benli Technology Co., Ltd. Proposes Final Cash Dividend for the Year 2023 CI
23/04 Zhejiang Benli Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 3,733 2,176 2,412
Enterprise Value (EV) 1 3,070 1,623 1,843
P/E ratio 55.6 x 36.6 x 40.6 x
Yield 0.66% 0.49% 0.44%
Capitalization / Revenue 6.01 x 2.87 x 3.46 x
EV / Revenue 4.94 x 2.14 x 2.64 x
EV / EBITDA 34.3 x 18 x 18.3 x
EV / FCF 6,341 x -21.7 x 650 x
FCF Yield 0.02% -4.61% 0.15%
Price to Book 3.08 x 1.74 x 1.86 x
Nbr of stocks (in thousands) 1,06,020 1,06,020 1,06,020
Reference price 2 35.21 20.52 22.75
Announcement Date 25/04/22 26/04/23 23/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 438 559.3 624.8 621.1 758.7 697.9
EBITDA 1 74.23 102.2 133.4 89.57 90.06 100.7
EBIT 1 51.66 76.97 101.3 52.51 43.38 47.77
Operating Margin 11.79% 13.76% 16.21% 8.45% 5.72% 6.84%
Earnings before Tax (EBT) 1 50.82 83.06 105.8 61.94 66.29 66.16
Net income 1 44.86 73.12 91.71 54.82 59.49 59.62
Net margin 10.24% 13.07% 14.68% 8.83% 7.84% 8.54%
EPS 2 0.5667 0.9200 1.153 0.6333 0.5600 0.5600
Free Cash Flow 1 68.8 -36.62 -4.463 0.4841 -74.87 2.833
FCF margin 15.71% -6.55% -0.71% 0.08% -9.87% 0.41%
FCF Conversion (EBITDA) 92.68% - - 0.54% - 2.81%
FCF Conversion (Net income) 153.39% - - 0.88% - 4.75%
Dividend per Share - - - 0.2333 0.1000 0.1000
Announcement Date 23/11/20 23/11/20 27/05/21 25/04/22 26/04/23 23/04/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - 1.69 - - -
Net Cash position 1 29.2 0.84 - 664 552 569
Leverage (Debt/EBITDA) - - 0.0126 x - - -
Free Cash Flow 1 68.8 -36.6 -4.46 0.48 -74.9 2.83
ROE (net income / shareholders' equity) 15.5% 21.4% 21.5% 6.51% 4.84% 4.69%
ROA (Net income/ Total Assets) 8.18% 10.1% 10.8% 3.3% 1.97% 2.07%
Assets 1 548.1 725.7 849.7 1,664 3,018 2,882
Book Value Per Share 2 3.860 4.760 5.960 11.40 11.80 12.20
Cash Flow per Share 2 0.2400 0.6400 0.5500 6.270 5.220 5.370
Capex 1 20.5 51.1 90 50 131 64
Capex / Sales 4.68% 9.14% 14.41% 8.04% 17.24% 9.17%
Announcement Date 23/11/20 23/11/20 27/05/21 25/04/22 26/04/23 23/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
ZHEJIANG BENLI TECHNOLOGY CO., LTD. Stock Zhejiang Benli Technology Co., Ltd.
-18.90% 264M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+39.30% 723B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+33.93% 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
-2.83% 369B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.04% 332B
ABBVIE INC. Stock AbbVie Inc.
+2.32% 282B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.81% 244B
NOVARTIS AG Stock Novartis AG
+9.46% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-4.95% 205B
PFIZER, INC. Stock Pfizer, Inc.
+1.22% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 301065 Stock
  4. Financials Zhejiang Benli Technology Co., Ltd.